-Member Login

Forgot your USERNAME OR PASSWORD?

Job Postings

Let's Stay Connected

Find us on the popular social networks

Facebook Twitter LinkedIn Flicker

Journal Highlights

MOL Highlight: Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy

Posted on 3/15/2017 3:14:01 PM

MOL April Highlights Chen et al 

Ionotropic glutamate receptors play important roles in normal brain development and are implicated in a wide range of neurologic disorders, including epilepsy. This paper investigates the molecular consequences of a somatic mutation identified in a child with profound global developmental delay and refractory epilepsy. The mutant receptor showed enhanced agonist potency, reduced sensitivity to endogenous negative inhibitors, prolonged synaptic-like response time course, increased single-channel mean open time, and increased channel open probability. The results are therefore consistent with this mutation causing overactivation and driving neuronal hyperexcitability. Molecular modeling further suggests that this mutation weakens the interaction between the transmembrane helices of the receptor and increases the dynamics of important linker regions of the receptor, leading to enhanced function. A number of glutamate receptor-targeted drugs, including U.S. Food and Drug Association–approved channel blockers, were evaluated for their ability to inhibit receptors containing this mutation as a first step towards exploring the potential for rescue pharmacology and personalized medicine.

See the article by Chen et al. at Molecular Pharmacology April 2017, 91 (4) 317-330; DOI: https://doi.org/10.1124/mol.116.106781 

Comments (0)


Leave a comment


Blog comments are moderated and will be posted once approved.

Name


Comment:


Enter the code shown below:

Recent Posts

Archive

.

Hot Links 

Advertise in Explore Pharmacology 2017 

2017 Award Nominations Side 

Join ASPET 

What is Pharmacology? Video 

PharmTalk Blog